The Italian inflection point: Clinical strength, culture and capital

In this episode of Denatured, you’ll hear from Diana Saraceni, founder and managing partner at Panakès Partners and Fabrizio Calisti, medical director at Angelini Ventures. We explore how Italy’s life sciences ecosystem has evolved over the last decade—from stronger tech transfer and growing venture capital to the gaps that still keep it from matching the UK, Germany or France in company creation and scale.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsDiana Saraceni, Founder and Managing Partner, Panakès PartnersFabrizio Calisti, Medical Director, Angelini VenturesDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.